Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study
View ORCID ProfileRhian Hopkins, Katherine G Young, Nicholas J Thomas, Angus G Jones, Andrew T Hattersley, Beverley M Shields, John M Dennis, Andrew P McGovern the MASTERMIND consortium
doi: https://doi.org/10.1101/2024.07.31.24311262
Rhian Hopkins
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
Katherine G Young
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
Nicholas J Thomas
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
Angus G Jones
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
Andrew T Hattersley
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
Beverley M Shields
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
John M Dennis
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
Andrew P McGovern
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
1Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
Article usage
Posted August 01, 2024.
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, Angus G Jones, Andrew T Hattersley, Beverley M Shields, John M Dennis, Andrew P McGovern
medRxiv 2024.07.31.24311262; doi: https://doi.org/10.1101/2024.07.31.24311262
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, Angus G Jones, Andrew T Hattersley, Beverley M Shields, John M Dennis, Andrew P McGovern
medRxiv 2024.07.31.24311262; doi: https://doi.org/10.1101/2024.07.31.24311262
Subject Areas
- Addiction Medicine (371)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12400)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4261)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2757)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4037)
- Nursing (216)
- Nutrition (599)
- Oncology (2127)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (470)
- Public and Global Health (6653)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)